Results 201 to 210 of about 756,649 (382)

Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma [PDF]

, 2017
Grace L. Smith, Madeleine Duvic, Zeinab Abou Yehia, Pamela K. Allen, Naveen Garg, Tina Suki, Sarah A. Milgrom, Chelsea C. Pinnix, Yasuhiro Oki, Joseph D. Khoury, Bouthaina S. Dabaja   +10 more
openalex   +1 more source

CRISPR‐Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl‐fumarate‐induced cell death

The FEBS Journal, EarlyView.
A genome‐wide CRISPR‐Cas9 screen identified H3K27 methylation as a key regulator of T‐cell lymphoma sensitivity to dimethyl fumarate (DMF). Specifically, inhibition of enhancer of zeste homolog 2 (EZH2) enhanced DMF‐induced cell death in malignant T cells. These results provide functional evidence for the role of EZH2 in modulating drug sensitivity and
Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller, Karsten Gülow   +17 more
wiley   +1 more source

Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. [PDF]

Acta Derm Venereol, 2022
Rouanet J, Joulie I, Lambert C, D'Incan M.   +3 more
europepmc   +1 more source

Quality and duration of responses with mogamulizumab in cutaneous T‐cell lymphomas: Insights into long‐lasting outcomes [PDF]

Alessandro Broccoli, Lisa Argnani, Alessandro Pileri, Camilla Mazzoni, Benedetta Sordi, Nicola Pimpinelli, Paolo Fava, Pietro Quaglino, Elsa Pennese, Tommasina Perrone, Andrea Bernardelli, Carlo Visco, Miriam Teoli, Leonardo Flenghi, Adalberto Ibatici, Cesare Massone, Pier Luigi Zinzani   +16 more
openalex   +1 more source

In situ study of T-cell subpopulations in cutaneous T-cell lymphoma: Diagnostic criteria [PDF]

, 1984
Anthony C. Chu, Jennifer Patterson, Carole L. Berger, Eric C. Vonderheid, Richard L. Edelson   +4 more
openalex   +1 more source

Acute lymphoblastic B‐cell leukemia or CAR‐T cell related skin changes – a relevant diagnostic challenge

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Farzan Solimani, Amrei Dilling, Konrad Heisterkamp, Frederik Damm, Olaf Penack, Christian Oberender, Philipp Le‐Coutre, Martina Rudelius, Kamran Ghoreschi, Alexander Nast   +9 more
wiley   +1 more source

Targeting the microbiota‐miRNA‐protease axis: A new therapeutic avenue in melanoma

The FEBS Journal, EarlyView.
Modulation of extracellular matrix (ECM) turnover is central to melanoma progression and metastasis, driven largely by ECM proteases. This review highlights the epigenetic regulation of ECM proteases by microRNAs and their roles in melanoma growth, invasion, and immune modulation.
Elias N. Katsoulieris, Paraskevi Ioannou, Nikolaos A. Afratis   +2 more
wiley   +1 more source

Evaluation of the International Society for Cutaneous Lymphoma Algorithm for the Diagnosis of Early Mycosis Fungoides. [PDF]

Cells, 2021
Ryu HJ, Kim SI, Jang HO, Kim SH, Oh SH, Park S, Kim SK.   +6 more
europepmc   +1 more source

RB1 inactivation in cutaneous carcinomas

Histopathology, EarlyView.
Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.
Tiffany Liv, Antoine Touzé, David Schrama, Serge Guyétant, Mahtab Samimi, Michael T Tetzlaff, Benjamin A Wood, Paul W Harms, Thibault Kervarrec   +8 more
wiley   +1 more source

Clinical Warburg Effect in a primary cutaneous lymphoma. [PDF]

Clin Hematol Int
Martins F, Fontinha G, Magalhães J, Cardoso JC, Calvão J.   +4 more
europepmc   +1 more source